Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044729 · ClinicalTrials.gov registry record · Early Phase 1
Mechanisms of CBD for Chronic Pain
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
NCT04044729 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 24 participants.
The verdict
NCT04044729, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a study designed to examine the neurochemical mechanisms associated with Cannabidiol (CBD) versus placebo for chronic non-cancer pain.
Interventions
- DRUG Placebo
- DRUG Cannabidiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-03-16 |
| Est. Completion | 2024-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04044729
The ClinicalTrials.gov registry entry for NCT04044729 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04044729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04044729 about?
NCT04044729 is a clinical study titled "Mechanisms of CBD for Chronic Pain". This is a study designed to examine the neurochemical mechanisms associated with Cannabidiol (CBD) versus placebo for chronic non-cancer pain.
What is the current status of trial NCT04044729?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2020-03-16. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT04044729?
The interventions under investigation include: Placebo (DRUG), Cannabidiol (DRUG).
Who is sponsoring clinical trial NCT04044729?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.